BIOLOGICAL · Unmapped registry intervention
Cizutamig
Find medicine records ·
Find other trials using this name
Clinical trial
A Phase 1 Study of Cizutamig in IgE Mediated Diseases
NCT07408869
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Phase 1 Study of Cizutamig in IgE Mediated Diseases
Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
IgE-Mediated Hypersensitivityunresolved
IgE Mediated Food Allergyunresolved
IgE-Mediated Cow Milk Allergyunresolved
Interventions
CizutamigBIOLOGICAL
Sponsors & collaborators
Candid Therapeuticslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07408869 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.